Drugs / methoxyphenamine
methoxyphenamine
also known as
Asmei · Methoxyphenamine hcl · METHOXYPHENAMINE HYDROCHLORIDE · Metoxifenamina · NSC-65644 · Orthoxine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT07103980 Comparator | Jul 2024 → Jul 2025 overdue | post-infectious syndrome | Shanghai Changzheng Hospital | Recruiting | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | methoxyphenamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07103980 ↗ |
| Known as | Asmei | “compound methoxyphenamine capsule ( "Asmei" 2 capsules oral TID)” NCT07103980 ↗ |
| Known as | Methoxyphenamine hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL2010507 ↗ |
| Known as | METHOXYPHENAMINE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2010507 ↗ |
| Known as | Metoxifenamina | ChEMBL registry synonym — accepted as the source's own label CHEMBL2010507 ↗ |
| Known as | NSC-65644 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2010507 ↗ |
| Known as | Orthoxine | ChEMBL registry synonym — accepted as the source's own label CHEMBL2010507 ↗ |
| Modality | Small molecule | — CHEMBL2010507 ↗ |
| Route | Oral | “2 capsules oral TID” NCT07103980 ↗ |